To be specific, the evaluation of the correlation between ALKBH5 levels and survival in CESC patients has revealed that increased ALKBH5 can regulate the SIRT3/ACC1 axis to inhibit CESC lipid metabolism and improve patient prognosis (93). The gene discussed is ALKBH5; the disease is cervical squamous cell carcinoma.